Open the map

HologicHOLX

Diagnostics · NASDAQ · USA

Up 2.0% this year. Hologic supplies 1 mapped company.

Market cap
$17B
This year
+2.0%
1 year
−3.5%
P/E
31.2
P/S
4.1
P/B
3.2

Supply chain

1 customer
SUPPLIERS →→ CUSTOMERSNone mappedQuest Diagnostics (DGX)DGXQuest Diagnostics+1.7%HOLXHologic

Customers 1

Open the full chain →

About Hologic

Women's health defines the range here, from molecular diagnostic tests to mammography systems and surgical products.

Theme exposure

DiagnosticsWomen's healthImaging

Products

  • Molecular diagnostics
  • Mammography systems
  • Surgical products

Competitors

Risks

  • Declining covid testing
  • Competition in imaging

Same segment: Diagnostics

Tests, imaging and assays that support clinical decision-making. Segment 6 of 8 in the Medicine, pharma & life science value chain.

Abbott LaboratoriesABT−0.2%NateraNTRA−1.2%IDEXX LaboratoriesIDXX+1.3%LabcorpLH+0.7%Quest DiagnosticsDGX+1.7%Bio-Rad LaboratoriesBIO−2.0%

Compare HOLX

Side by side with the largest companies in the same segment.

HOLX vs ABTHOLX vs NTRAHOLX vs IDXXHOLX vs LHHOLX vs DGXHOLX vs BIO

See where Hologic sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.

Open the Life science value chain →